VII

Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on Operational Progress

Retrieved on: 
Monday, May 9, 2022
COL7, Safety, Degenerative disease, Skin, KRYS, SEC, Twitter, NASDAQ, Director, Company, Private Securities Litigation Reform Act, Dermatology, Patient, Clinical trial, Program, Lung, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, CF, LinkedIn, Biology, Board of directors, Investment, EMA, IND, U.S. Securities and Exchange Commission, Research, Krystal, DEB, Cohort, NCT, MPH, MBA, Ageing, Financial result, Board, Jeune, N. S. Krishnan, GLOBE, European Medicines Agency, Food, Doctor of Philosophy, Coronavirus Scientific Advisory Board (Turkey), Marketing, American Academy, Nature Medicine, VII, Pharmaceutical industry, Video game, Medical device, Online gambling

New GEM-3 Phase 3 results for B-VEC were presented at the 2022 American Academy of Dermatology Annual Meeting.

Key Points: 
  • New GEM-3 Phase 3 results for B-VEC were presented at the 2022 American Academy of Dermatology Annual Meeting.
  • Financial results for the quarter ended March 31, 2022:
    Cash, cash equivalents, and investments totaled $468.0 million on March 31, 2022.
  • General and administrative expenses for the first quarter ended March 31, 2022 were $15.9 million, compared to $8.2 million for first quarter 2021.
  • For additional information on the Companys financial results for the first quarter ended March 31, 2022, refer to form 10-Q filed with the SEC.

Gloucester County Superintendent Named Virginia Superintendent of the Year

Retrieved on: 
Monday, May 2, 2022
G.G. v. Gloucester County School Board, VIII, Student, Newport News Public Schools, GLOBE, Virginia Board of Health, Supervision, Safety, Superintendent, American Association of School Administrators, Association, WBCA National Coach of the Year Award, III, American Association, Leadership, Learning, Health, Virginia Association, VASS, VII, Assistant, Curriculum, Charlotte-Mecklenburg Schools, Management, Janitor

ROANOKE, Va., May 02, 2022 (GLOBE NEWSWIRE) -- Dr. Walter "Rick" Clemons, Superintendent of Gloucester County Schools, was named Virginia Superintendent of the Year at the Virginia Association of School Superintendents (VASS) Annual Awards Luncheon today in Roanoke.

Key Points: 
  • ROANOKE, Va., May 02, 2022 (GLOBE NEWSWIRE) -- Dr. Walter "Rick" Clemons, Superintendent of Gloucester County Schools, was named Virginia Superintendent of the Year at the Virginia Association of School Superintendents (VASS) Annual Awards Luncheon today in Roanoke.
  • He was selected by the Presidents of the Virginia Board of Education, the Virginia Education Association, the Virginia Parent and Teacher Association, the Virginia School Boards Association, the Virginia Association for Supervision and Curriculum Development, the Virginia Association of Elementary School Principals, and the Virginia Association of Secondary School Principals, and the President, President-elect and Secretary/Treasurer of the Virginia Association of School Superintendents.
  • He continued in Franklin City as the school division's Assistant Superintendent before accepting his first superintendent position in Northampton County, where he served for three years before his current post as Superintendent of Gloucester County Schools where he has remained for the past eight years.
  • The Regional Superintendents of the Year include:
    Region I - William D. Sroufe, Division Superintendent, Colonial Heights City
    Region II - Victor D. Shandor, Division Superintendent, York County
    Region III - Walter R. Clemons, Division Superintendent, Gloucester County
    Region IV - Gregory C. Hutchings, Jr., Division Superintendent, Alexandria City
    Region V - Eric W. Bond, Division Superintendent, Augusta County
    Region VI - Mark L. Miear, Division Superintendent, Montgomery County
    Region VII - Keith S. Perrigan, Division Superintendent, Bristol City
    Region VIII - Kristy N. Somerville-Midgette, Division Superintendent, Brunswick County

Volaris announces resolutions of general ordinary annual shareholders meeting

Retrieved on: 
Wednesday, April 27, 2022
World Health Organization, Sale, Compensation, Central, Audit, United States National Sex Offenders Public Registry, BMV, National Bank of the Kyrgyz Republic, Model Business Corporation Act, Committee, Securities market, Nomination, VI, World, Volaris, NYSE, Section, Person, Company, VII, Mexican Stock Exchange, Annual, Chief, Security deposit, Securities commission, Lluís Companys, Board of directors, MEXICO, COVID-19, Secretary, Mission statement, Telephone, City, MXN, Nature, Board, General Laws of Massachusetts, USD, Financial statement, Executive, Friends, Commerce, S.A, Compliance, Aircraft, Naraporn Chan-o-cha, Holding company, Management, Airline, Medical device, Television, Convenience food, Security (finance), Online gambling, Insurance, Cryptocurrency, Coronavirus, Director

MEXICO CITY, April 27, 2022 /PRNewswire/ -- Volaris* (NYSE: VLRS and BMV: VOLAR), announces the resolutions of the general ordinary annual shareholders meeting held on April 26, 2022.

Key Points: 
  • MEXICO CITY, April 27, 2022 /PRNewswire/ -- Volaris* (NYSE: VLRS and BMV: VOLAR), announces the resolutions of the general ordinary annual shareholders meeting held on April 26, 2022.
  • The general ordinary annual shareholders meeting of the Company authorized all the items of the agenda with the majority of the votes.
  • A courtesy English translation of the shareholders' meeting resolutions summary are attached as an exhibit.
  • de C.V. (the "Company")
    Summary of the Resolutions Adopted by the Annual General Ordinary Shareholders' Meeting held on April 26, 2022.

Resolutions Adopted at the General Ordinary Shareholders’ Meeting and Extraordinary Shareholders’ Meeting for Grupo Aeroportuario Del Pacifico On April 22, 2022

Retrieved on: 
Monday, April 25, 2022
Annual report, Board, Annual, PAC, VII, TEN, VI, Article, International, Compliance, Board of directors, GLOBE, TWO, PS, Audit, II, Series, III, Mission statement, Mexican, Prayut Chan-o-cha, Company, Share repurchase, General officer, NYSE, IFRS, International Financial Reporting Standards, Income, Section, BMV, Sustainability reporting, Grupo Aeroportuario del Pacífico, Online gambling, Pension fund, Holding company, Director

GUADALAJARA, Mexico, April 25, 2022 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacifico, S.A.B.

Key Points: 
  • GUADALAJARA, Mexico, April 25, 2022 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacifico, S.A.B.
  • Report on transactions and activities undertaken by the Companys Board of Directors during the fiscal year ended December 31, 2021, pursuant to the Mexican Securities Market Law.
  • The dividend will be payable in one or more installments within 12 (twelve) months after April 22, 2022.
  • RATIFICATOIN of the four members of the Board of Directors and their respective alternates appointed by the Series BB shareholders as follows:

One Equity Partners Closes $2.75 Billion Private Equity Fund

Retrieved on: 
Wednesday, April 13, 2022
Professional Services, Finance, Momentum, Carbon, Health, Foundation, LLP, JPMorgan Chase, VII, Ridgemont Equity Partners, VIII, One Equity Partners, Kirkland & Ellis, Founder, Technology, RV Atlantis, Insurance, Investment, Glass, Partner, OEP, Financial services, Security (finance)

One Equity Partners (One Equity and OEP), a middle market private equity firm, today announced the closing of One Equity Partners VIII, L.P. (OEP VIII), with committed capital of $2.75 billion.

Key Points: 
  • One Equity Partners (One Equity and OEP), a middle market private equity firm, today announced the closing of One Equity Partners VIII, L.P. (OEP VIII), with committed capital of $2.75 billion.
  • The closing of OEP VIII brings the firms combined assets under management and committed capital to approximately $10 billion.
  • OEPs previous fund, One Equity Partners VII, L.P., closed in 2019 with $1.75 billion in commitments.
  • One Equity Partners is a middle market private equity firm focused on the industrial, healthcare, and technology sectors in North America and Europe.

Allianz Trade Global Survey 2022

Retrieved on: 
Tuesday, April 12, 2022
Banking, Professional Services, Insurance, Finance, COVID-19, Allianz, Corporation, Pulse, XI, VII, Euler Hermes, Transport, AA, Diving, VIII, Cologne Institute for Economic Research, III, Growth, Mortality, IX, United Kingdom, GDP, Virginia Tech Corporate Research Center, Disease, Economy, APAC, Trading strategy, VI, Renewable energy, Drug, Oil, Online gambling, Bank, Financial services, Risk management, Brexit

Before diving into the results of our Allianz Trade Global Survey, lets take a look at our economic outlook.

Key Points: 
  • Before diving into the results of our Allianz Trade Global Survey, lets take a look at our economic outlook.
  • In such an adverse scenario, global inflation would soar to 7% this year while growth would decline to +2.5% before the global economy enters into a recession 2023 (-0.3%), adds Ana Boata, Global Head of Economic Research at Allianz Trade.
  • Even if Russia and Ukraine are not key final markets for European exporters, the war situation is affecting global trade through indirect effects (supply chains, raw material, energy), weighing on export opportunities for firms, adds Franoise Huang, Senior Economist for Global Trade and APAC at Allianz Trade.
  • We predict trade and credit risk today, so companies can have confidence in tomorrow
    Allianz Trade is the global leader in trade credit insurance and a recognized specialist in the areas of surety, collections, structured trade credit and political risk.

5AM Ventures Closes $750 Million Across Two Life Science Funds and Announces Team Additions

Retrieved on: 
Monday, April 4, 2022
Drug development, Therapy, Degenerative disease, Leadership, Norwest Venture Partners, Investment, Growth, VII, Venture management, Sutro Biopharma, Specialty, Doctor of Philosophy, General manager, Moderna, CEO, Bristol Myers Squibb, Senior, MD, LLC, Biochemical engineering, GLOBE, Solution, SAN, Amgen, Management, Pharmaceutical industry

5AM Ventures VII, L.P. is a $450 million early-stage venture capital fund which will expand 5AMs efforts to discover, incubate and invest in breakthrough life science companies.

Key Points: 
  • 5AM Ventures VII, L.P. is a $450 million early-stage venture capital fund which will expand 5AMs efforts to discover, incubate and invest in breakthrough life science companies.
  • 5AM Opportunities II, L.P. is a $300 million later-stage fund which will invest in both 5AM portfolio companies and non-5AM companies in the private and public markets.
  • These additions strengthen and expand the 5AM team to support our model of a focused and engaged approach to company building.
  • Founded in 2002, 5AM Ventures is a leading venture capital firm focused on building next-generation life science companies.

Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) of Beremagene Geperpavec (B-VEC) Data in Nature Medicine

Retrieved on: 
Monday, March 28, 2022
Risk, LinkedIn, Tears, NASDAQ, Private Securities Litigation Reform Act, Degenerative disease, COL7, Lung, Krystal, Epidermis, Marketing, Suma, Clinical trial, VII, KRYS, Skin, Dermis, Stanford University School of Medicine, Research, DEB, Associate, Tissue, Â, Priority, COL7A1, Finger, Twitter, U.S. Securities and Exchange Commission, Concha bullosa, Securities and Exchange Commission (Philippines), GLOBE, EMA, The, Squamous cell carcinoma, Blister, Fibrosis, Palliative care, Trauma, Development, Stanford University Medical Center, FDA, Patient, Disease, Research and development, Pharmaceutical industry, RDEB, Nature Medicine, Dermatology

We are grateful to the trial participants who made this study possible.

Key Points: 
  • We are grateful to the trial participants who made this study possible.
  • The lack of functional anchoring fibrils in DEB patients leads to extremely fragile skin that blisters and tears from minor friction or trauma.
  • However, while Krystal may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.
  • These forward-looking statements should not be relied upon as representing Krystals views as of any date subsequent to the date of this release.

Euler Hermes is now Allianz Trade

Retrieved on: 
Monday, March 28, 2022
Allianz, Heart, VIII, XI, III, Growth, Mortality, Board, VII, Excess, CEO, Intelligence, VI, Knowledge, Ecosystem, GLOBE, Euler Hermes, AA, Disease, Solution, IX, Awareness, Risk management, Retail, Bank

PARIS, March 28, 2022 (GLOBE NEWSWIRE) -- Today marks a new chapter in our story: Euler Hermes, the world leader in trade credit insurance, becomes Allianz Trade a natural move as we have been fully part of the Allianz Group since 2018.

Key Points: 
  • PARIS, March 28, 2022 (GLOBE NEWSWIRE) -- Today marks a new chapter in our story: Euler Hermes, the world leader in trade credit insurance, becomes Allianz Trade a natural move as we have been fully part of the Allianz Group since 2018.
  • Changing our brand name to Allianz Trade means reinforcing our position as a global player.
  • Chris Townsend, member of the Board of Management of Allianz SE, adds: We are excited to see Euler Hermes become Allianz Trade and are convinced that the change will bring about many benefits in terms of awareness, business development, growth and innovation.
  • We predict trade and credit risk today, so companies can have confidence in tomorrow
    Allianz Trade is the global leader in trade credit insurance and a recognized specialist in the areas of surety, collections, structured trade credit and political risk.

FG Acquisition Corp. Files Preliminary Prospectus For Its Initial Public Offering

Retrieved on: 
Monday, March 21, 2022
Offering, Company, LLP, Principal, Warrant, Sale, Forward-looking statement, Goodmans, Legislation, Toronto Stock Exchange, Underwriting, VII, SEDAR, Norton Rose Fulbright, Fortress Investment Group, TSX, Prospectus, LLC, Industry, Intention, Senior advisor, Investment, Sponsor, Canaccord Genuity, IPO, Acquisition, Security (finance), 3D printing, Risk management

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- On March 18, 2022, FG Acquisition Corp. (the “Company”) filed a preliminary prospectus (the “Preliminary Prospectus”) with the securities regulatory authorities in each of the provinces and territories of Canada, other than Quebec, in respect of a proposed initial public offering (the “Offering”) of Class A restricted voting units (the “Class A Restricted Voting Units”) at a price of U.S.$10.00 per unit for aggregate gross proceeds of U.S.$100,000,000. The aggregate gross proceeds from the distribution of the Class A Restricted Voting Units will be deposited into an escrow account and will only be released upon certain prescribed conditions. On March 21, 2022, the Company obtained a receipt for the Preliminary Prospectus with the securities regulatory authorities in each of the provinces and territories of Canada, other than Quebec.

Key Points: 
  • The Class A Restricted Voting Units are intended to begin trading on the TSX promptly after the closing of the Offering (the Closing).
  • The Preliminary Prospectus contains important information relating to the Offering and is still subject to completion or amendment.
  • The Preliminary Prospectus has not yet become final for the purpose of a distribution of securities to the public.
  • FG Acquisition Corp. is a newly organized special purpose acquisition company incorporated under the laws of British Columbia for the purpose of completing a Qualifying Acquisition.